As the global population undergoes a profound demographic shift toward an older age profile, the prevalence of age-related physical decline…
Read More
Macau Approves ImmunityBio’s Anktiva for Bladder Cancer, Marking First Asian Regulatory Milestone
ImmunityBio has achieved a significant regulatory victory with the Pharmaceutical Administration Bureau (ISAF) of the Macau Special Administrative Region, China,…
Read More
Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy
Researchers at Johns Hopkins Kimmel Cancer Center have introduced a groundbreaking advancement in liquid biopsy technology, demonstrating that measuring the…
Read More
Novartis Acquires Promising Breast Cancer Drug SNV4818 from Synnovation Therapeutics for Up to $3 Billion
Novartis has announced a significant strategic move to bolster its oncology pipeline with the acquisition of SNV4818, an investigational oral…
Read More
Bugs deliver drugs: weaponizing bacteria to target colorectal cancer therapy
A groundbreaking scientific endeavor, spearheaded by a collaborative team of researchers from Baylor University (TX, USA), Texas Tech University Health…
Read More
Houston Methodist Researchers Identify TDP43 Protein as a Key Regulator of DNA Mismatch Repair Linking Neurodegeneration and Cancer
In a landmark study that bridges two historically distinct fields of medicine, researchers at the Houston Methodist Research Institute have…
Read More
Johns Hopkins Researchers Uncover Molecular Mechanism Behind Rare Kidney Cancer Progression via Liquid Condensates
In a significant advancement for the field of molecular oncology, a collaborative study led by investigators at the Johns Hopkins…
Read More
Breakthrough Research Uncovers Blood Metabolite Signatures for Earlier Gallbladder Cancer Detection, Promising Non-Invasive Diagnostics
A groundbreaking collaborative effort between researchers at Tezpur University in India and the University of Illinois Urbana-Champaign has successfully identified…
Read More
Researchers Create First Fully Human 3D Bone Marrow Model to Advance Cancer Treatment and Reduce Animal Testing
In a landmark development for regenerative medicine and oncology, scientists at the University of Basel and University Hospital Basel have…
Read More
Leading Nanomedicine Experts Unveil Definitive Guide to Cancer Applications, Addressing Translational Hurdles and Charting Future Innovations
Liverpool John Moores University (LJMU) Professor of Nanomedicine, Imran Saleem, and Qassim University Professor of Pharmaceutics, Ahmed AH Abdellatif, long-time…
Read More
